Tie2, an endothelial-cell-specific receptor tyrosine kinase, collaborates with vascular endothelial growth factor (VEGF) in regulating angiogenesis and vascular maturation. Here, we report a mutation of glycine to aspartic acid at the second glycine of the GXGXXG motif of Tie2 ( G833D Tie2) in human intramuscular haemangiomas (IMHs) of the capillary type. Murine endothelial cells (ECs) overexpressing this
Tie2, an endothelial-cell-specific receptor tyrosine kinase, collaborates with vascular endothelial growth factor (VEGF) in regulating angiogenesis and vascular maturation. Here, we report a mutation of glycine to aspartic acid at the second glycine of the GXGXXG motif of Tie2 ( Keywords: Tie2; VEGF; haemangioma; angiosarcoma; endothelial cell Intramuscular haemangiomas (IMHs) are benign vascular tumours characterized by infiltrating growth in skeletal muscle. IMHs are divided into capillary, cavernous, or mixed type depending on their gross and microscopic appearances. Capillary type is composed of a disordered proliferation of small vessels, whereas cavernous type is large, thin-walled, dilated vessels by flattened endothelial cells (ECs). The current treatment, surgical ablation of the tumour, is only partially effective. More than 18% of patients suffered local recurrence (Enzinger and Weiss, 1995) . The precise pathogenic mechanisms of IMH remain to be elucidated.
Tie2 is an endothelium-specific receptor tyrosine kinase consisting of an extracellular domain, a transmembrane domain, and a split intracellular kinase domain (Dumont et al., 1992 (Dumont et al., , 1994 . Mutational analyses of the Tie2 gene have demonstrated that the receptor plays a critical role in the maintenance of ECpericyte communication during vascular morphogenesis (reviewed in Folkman and D'Amore, 1996; Hanahan, 1997) . In the present study, we identified two point mutations in the Tie2 kinase domain from 37 haemangioma samples: a G2646A change resulting in a glycine to aspartic acid substitution at residue 833 (G833D) in eight unrelated patients and another A2659T change resulting in a glutamine to histidine substitution at residue 837 (Q837H) in one patient (Figure 1a and b). The relative of these patients did not have a history of IMH. To confirm the sequencing result, the PCR products of the patients, their relatives, and controls were analysed using restriction endonuclease assay. The two mutations were not present in any of 50 control individuals or in other probands tested. All of the patients with the G833D mutation had a large disfiguring lesion affecting one side of the face, and associated early postoperative recurrence, whereas the patient with the Q837H mutation had no recurrence during postoperative follow-up after 5 years. Histological sections of the G833D tumours showed a number of small capillary-sized vessels that extended between individual muscle fibres. No evidence of enlarged vessels was observed ( Figure 1c ). Immunohistochemical analysis indicated that the expression of Tie2 protein was moderate in G833D-tumour ECs (Figure 1d) , and the expression of vascular endothelial growth factor (VEGF) protein was upregulated (Figure 1e ) when compared to human normal muscular tissue (Figure 1h) . However, the Q837H tumour comprised large dilated thin-walled vessels lined with flattened endothelium (Figure 1f ). Although the expression of Tie2 protein was moderate in Q837H-tumour ECs, the expression of VEGF protein was unable to be detected (data not shown). Pathological evaluation revealed that the G833D tumours were IMHs of the capillary type, whereas the Q837H lesion was an IMH of the cavernous type.
To characterize the biological effects of the two mutations, we generated the corresponding mutant receptor cDNAs in a Tie2 mammalian expression vector by site-directed mutagenesis ( Figure 2a ) and analysed them by transient transfection.
G833D
Tie2 showed a 2.9-fold increase in ligand-independent autophosphorylation relative to wild-type Tie2, whereas Q837H Tie2 showed a 20-fold increase relative to wild-type Tie2 (Figure 2b ). Tie2 stimulated activation of STAT3 more strongly than G833D Tie2. In contrast, wild-type Tie2 did not exhibit phosphorylation of STAT3 without ligand stimulation. These data indicate that the G833D and Q837H mutations in Tie2 result in ligand-independent hyperphosphorylation of the receptor and promote the tyrosine phosphorylation of STAT3.
The ability of the kinase-activated mutants to induce transformation was examined in vitro and in vivo. Western blot analysis showed that there was no significant difference in Tie2 protein expression among MSS31 G833D , MSS31 Q837H , and MSS31 wild-type cells ( Figure 2e ). The morphology of MSS31 cells transfected with G833D, Q837H, wild-type Tie2, or vector (MSS31 G833D , MSS31 Q837H , MSS31 wild-type , or MSS31 vector , respectively) was similar to the morphology of primary ECs in culture. They formed no colonies in the anchorage-independent growth assay in threedimensional collagen gels. However, MSS31 G833D growth was significantly faster, and MSS31 wild-type growth was significantly slower when compared with MSS31 vector or MSS31 Q837H when cultured with 0.5% serum ( Figure 2f ). This result implies that Tie2 signalling might mediate EC growth and that the G833D mutant enhances EC proliferation. Tie2 activity is normally regulated by the opposing actions of agonistic and antagonistic ligands. Of them, an antagonistic ligand of Tie2 (Ang2) is expressed in EC in autocrine manner (Oh et al., 1999) . The decreased proliferation of MSS31 wildtype in significant low serum raises the possibility that the growth inhibition might have resulted from the autocrine regulation of the ligand or the others. Additional studies, such as an investigation of the ligands on the transfectants, will be necessary to clarify the issue. In vivo studies showed that all 10 mice inoculated with 5 Â 10 6 MSS31 G833D cells produced tumours after 8-13 weeks (Figure 3a) , whereas mice inoculated with the same number of MSS31 Q837H , MSS31 wild-type , or MSS31 vector cells did not develop tumours. Early tumours had a solid cellular appearance with an ability to either replace the muscles or infiltrate adjacent muscles (Figure 3b) . By 20 weeks after implantation, the tumours had grown to 42 cm in diameter (Figure 3c) . Microscopically, the tumours were composed of irregular anastomosing channels lined with pleomorphic, hyperchromatic ECs with abnormal mitotic activity (Figure 3d ). Pathological evaluation revealed that the tumours were angiosarcomas. These results demonstrate that G833D Tie2 induces malignant transformation of murine ECs.
Immunohistochemical analysis of xenograft tumour cells showed that either Tie2 (Figure 3g and k) or the EC-specific marker (Figure 3f and j), CD31 (platelet and EC adhesion molecule), was expressed in xenograft tumour cells, which is consistent with the immunohistochemical character of vascular tumours (Enzinger and In all, 37 haemangioma specimens were obtained from patients referred to the second military medical university and Hiroshima University. Paraffin blocks, blood samples, and the medical histories were obtained with informed consent. The study protocol was reviewed and approved by the appropriate Ethics Committees. The N-terminal domain of Tie2 kinase was amplified using the PCR primers 5 0 -AACCAGCTGTGCAGTTCAAC-3 0 and 5 0 -TCATTCTTTTGATGGCAGCATC-3 0 with genomic DNA as template, generating a 201-bp product. Three microlitres of each PCR product was diluted to 6 ml with denaturing loading buffer for analysis of single-stranded conformation-dependent polymorphism (SSCP). Samples that produced a heteroduplex shift were cloned into the pCRII vector (Invitrogen, Carlsbad, CA, USA) and sequenced in an automated sequencer (ABI 310 Prism; PE Applied Biosystems). , 1995) . PCNA (proliferating cell nuclear antigen) protein was prominent in the nucleoli of the tumour cells (Figure 3e and i) . Notably, upregulation of VEGF expression was observed in G833D-transfected MSS31 cells in vivo (Figure 3h and l) . VEGF specifically stimulates EC growth and induces angiogenesis in vivo (Leung et al., 1989) . Moreover, the upregulation of VEGF expression induces haemangiomas within mouse muscles (Springer et al., 1998; Lee et al., 2000) . To establish a correlation between VEGF expression and the Tie2 signal, we examined the levels of VEGF and Tie2 mRNA in transfected cells (Figure 4a ). Northern blot analysis showed that there was no significant difference in Tie2 mRNA expression among MSS31 G833D , MSS31 Q837H , and MSS31 wild-type cells. However, MSS31 G833D cells expressed more VEGF mRNA than MSS31 wild-type or MSS31 Q837H cells when cultured with 0.5% serum. Moreover, all of the transfectants increased VEGF mRNA expression when stimulated with Ang1 (data not shown). These results suggest that Tie2 signalling is important for normal levels of VEGF expression and that perturbation of Tie2 signalling by the G833D mutation induces constitutive VEGF expression. Figure 2 Effects of the mutants on Tie2 activation and EC proliferation. Full-length human Tie2 cDNA was ligated into the pALTER-MAX vector. Either the G833D or Q837H mutation was introduced by site-directed mutagenesis using the Altered Sites II Mammalian Mutagenesis System (Promega Corporation, Madison, WI, USA). MSS31 cell lines were maintained in RD medium (a 1 : 1 mixture of RPMI-1640 and Dulbecco's modified Eagle's medium) supplemented with 5% calf serum (Hy Clone Laboratories Inc., Logan, UT, USA). Empty mammalian expression vectors or vectors carrying full-length cDNA encoding the G2646A or A2659T mutation, or normal Tie2 cDNA, were transfected into MSS31 using the calcium phosphate method. (a) A schematic diagram of Tie2 indicating the location of the two missense mutations. (b) Tie2 tyrosine phosphorylation. Cell lysates were immunoprecipitated with 2 mg of Tie2 antibody and analysed by Western blotting using anti-phosphotyrosine antibodies (p-Tyr, Upstate Biotechnology Inc., Lake Placid, NY, USA), and then reprobed the membrane with Tie2 antibodies followed by enhanced chemiluminesence. The signal intensities in the blots were quantified by the Bio-Imaging analyzer system (ATTO Densito graph, Tokyo Japan). Lanes are designated as NC (incubated without Ang1) and Ang1 (incubated with Ang1). All experiments were performed in triplicate. (c and d) For the analysis of the receptors activation in a Tie2 ligand-dependent system, the stably transfected cells were nutrition starved for 24 h and stimulated then for 5 min at 371C with or without 30 ng/ml of Ang1 (Upstate Biotechnology Inc.). Western blotting for STAT3 was performed using PhophoPlus t Antibody Kit (New England Biolabs Inc., Beverly, MA, USA) and detected by enhanced chemiluminescence. The fold activation of p-Tie2 and p-STAT3 was calculated as a ratio of p-Tie2/Tie2 and p-STAT3/STAT3 levels quantified by the Bio-Imaging analyzer system. Each sample was assayed in triplicate and error bars indicate the standard deviations from the means. (e) Western blot analysis of Tie2 protein expression in stably transfected murine EC line MSS31. (f) Effect of the mutants on EC proliferation. These transfectants (3 Â 10 3 cells/well) were seeded onto 24-well culture plates and counted daily for 6 days with a Coulter Counter (Coulter Electronics, Hialeah, FL, USA). MSS31 Q837H (&), MSS31 vector (E), and MSS31 wild-type (W) had doubling times of 4773.98, 5474.04, and 6875.49 h, respectively, whereas MSS31 G833D (J) proliferated with a doubling time of 33.271.47 h. The doubling time of MSS31 G833D growth was significantly shorter, whereas the doubling time of MSS31 wild-type was significantly longer when compared with MSS31 vector or MSS31 Q837H . Po0.01 by one-way ANOVA followed Dunnett's multiple comparison test
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The G833D mutation occurs at the second glycine residue of the GXGXXG motif (residues 832-835) within the nucleotide-binding loop, whereas Q837H affects the glutamine adjacent to the third glycine. Glycine is an anomaly among the 20 amino acids, because it lacks a side chain. Thus, it is able to participate in extremes of bending and folding of the polypeptide backbone and is the strongest breaker of ahelices. Structural analysis suggests that these residues around G833, such as E832, N834, and F835, form a self-inhibitory conformation with the neighbouring molecule as a safeguard against abnormal ATP binding (Shewchuk et al., 2000) . Incorporation of the much larger aspartic acid at residue 833 may destabilize the self-inhibitory conformation, thus locking it in the ATPbinding state. Importantly, the three glycine residues of the GXGXXG motif are highly conserved in the human receptor kinases so far examined (Figure 4b ) and even in the nonreceptor kinases such as Ras protein. The glycine residues provide the flexibility necessary for anchoring the triphosphate moiety of ATP in the correct position for catalysis (Spitaler et al., 2000) . Therefore, mutations at these glycines may directly affect the ATP or ADP binding and the hydrolysis of ATP. In Ras proteins, substitution of the second glycine with any amino acid except proline endows the Ras protein with transforming activity (Reddy et al., 1982; Taparowsky et al., 1982; Tong et al., 1989) . Notably, this mutation of the second glycine in Ras protein decreases GTPase activity, suggesting it has an important role in GTPase activity. If glycine 833 in Tie2 is similarly involved in enzyme activity, its substitution by an acidic and hydrophilic residue (aspartic acid) could reduce the regulatory action of ATP hydrolysis so that the mutant Tie2 remains continuously activated. The
G833D
Tie2 mutant, which is found in benign human vascular tumours, induces malignant vascular tumours in nude mice. This discrepancy may arise because the capacity of mouse cells to become fully transformed is enormously greater than that of human cells (Balmain and Harris, 2000) . It has been suggested that immortalized mouse cell lines have less efficient DNA repair, poorer control of genetic stability, or altered control of gene expression through DNA methylation (Holliday, 1996; Balmain and Harris, 2000) . Immortalized murine cell lines, typically fibroblasts, are preneoplastic and malignant transformation will routinely result from the introduction of a single oncogenic alteration. However, malignant transformation of primary human fibroblasts or epithelial cells requires at least four alterations (Balmain and Harris, 2000) . On the other hand, the induction here of mice angiosarcomas also raises the possibility that the G833D mutation occurs in angiosarcomas. Consistent with observations in human angiosarcomas (Brown et al., 2000) , our experiment suggests that perturbation of Tie2 signalling may play important roles in the pathogenesis of both IMHs and angiosarcomas.
We have shown that the G833D mutation in the Tie2 receptor induces transformation of murine vascular ECs, as defined by the enhancement of EC proliferation and angiosarcoma formation. Human IMHs are benign, nonmetastatic tumours. The high postoperative recurrence of IMHs has previously been attributed to incomplete excision. This was based on their localization in deep muscle and their infiltrative growth, which make tumour resection difficult (Enzinger and Weiss, 1995) . The data presented here, however, demonstrate that there are significant characteristics of the G833D mutation with respect to transforming activity and VEGF expression. These characteristics could reflect clinical phenotype of early postoperative recurrence in the human G833D IMHs. Our results and subsequent elucidation of Tie2-mutant-mediated signalling properties may be useful in terms of diagnosis of and possible therapy for various forms of IMH with Tie2 as a target. They may also extend our understanding of receptor kinase function in vascular development.
